Abstract
The microbial transformation of anabolic androgenic steroid mestanolone (1) with Macrophomina phaseolina and Cunninghamella blakesleeana has afforded seven metabolites. The structures of these metabolites were characterized as 17-hydroxy-17-methyl-5-androsta-1-ene-3,11-dione (2), 14,17-dihydroxy-17-methyl-5-androstan-3,11-dione (3), 17-hydroxy-17-methyl-5-androstan-1,14-diene-3,11-dione (4), 17-hydroxy-17-methyl-5-androstan-3,11-dione (5), 11,17-dihydroxy-17-methyl-5-androstan-1-ene-3-one (6), 9,11,17-trihydroxy-17-methyl-5-androstan-3-one (7), and 1,11,17-trihydroxy-17-methyl-5-androstan-3-one (8). All the metabolites, except 5 and 6, were identified as new compounds. Substrate 1 (IC50 = 27.6 +/- 1.1 M), and its metabolites 2 (IC50 = 19.2 +/- 2.9 M) and 6 (IC50 = 12.8 +/- 0.6 M) exhibited moderate cytotoxicity against the HeLa cancer cell line (human cervical carcinoma). All metabolites were noncytotoxic to 3T3 (mouse fibroblast) and H460 (human lung carcinoma) cell lines. The metabolites were also evaluated for immunomodulatory activity, and all were found to be inactive.